Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Department of Defense, Washington Headquarters Services, Directorate for Information 
U.S. Army Medical Research and Materiel Command Fort Detrick, Maryland 21702-5012

SPONSOR/MONITOR'S REPORT NUMBER(S)
DISTRIBUTION / AVAILABILITY STATEMENT
Approved for Public Release; Distribution Unlimited
SUPPLEMENTARY NOTES
ABSTRACT
We propose a randomized controlled clinical trial of 1,200 military service members who are at increased risk for suicide but not currently in behavioral health treatment for the purpose of determining if a brief intervention improves the initiation of treatment. Participants assigned to the treatment condition will be presented an individualized CB intervention. The CB intervention takes 45-60 minutes, is delivered by phone, and has been shown to promote treatment-seeking including in a preliminary study of OEF/OIF Veterans with elevated posttraumatic stress disorder (PTSD) symptoms. Participants will be assessed at baseline and at 1-month, 3-month, and 6-month follow-up. Analyses are based on logistic and mixed effect models. Participants receiving the cognitive-behavioral (CB) intervention will have significant increases in positive attitudes about treatment at 1-month follow-up compared to controls. Hypothesis 1b: Participants receiving the CB intervention will have significant increases in the intention to initiate behavioral health treatment compared to controls.
Test the effectiveness of the intervention on the initiation of and adherence to behavioral health treatment. Hypothesis 2a:
Participants receiving the CB intervention will be more likely to initiate behavioral health treatment than participants in control group during 6-month follow-up. Hypothesis 2b: Participants receiving the CB intervention will attend more behavioral health treatment sessions than participants in the control group over 6-month follow-up.
Study Design:
We propose a randomized controlled clinical trial of 1,200 military service members who are at increased risk for suicide but not currently in behavioral health treatment for the purpose of determining if a brief intervention improves the initiation of treatment. Participants assigned to the treatment condition will be presented an individualized CB intervention. The CB intervention takes 45-60 minutes, is delivered by phone, and has been shown to promote treatment-seeking including in a preliminary study of OEF/OIF Veterans with elevated posttraumatic stress disorder (PTSD) symptoms. Participants will be assessed at baseline and at 1-month, 3-month, and 6-month follow-up. Analyses are based on logistic and mixed effect models.
Relevance: Reducing suicide among our service members is a national priority. The passage of the Joshua Omvig Veterans Suicide Prevention Act highlights the importance that stakeholders place on developing and implementing a comprehensive program to reduce suicide among U.S. service members and Veterans. We are conducting a randomized controlled clinical trial of 1,200 military service members who are at increased risk for suicide but not currently in behavioral health treatment for the purpose of determining if a brief intervention improves attitudes toward behavioral health treatment and initiation of treatment. Advertisements are used to recruit service members who report current suicidal ideation or a history of suicide attempt on standard screening items, suggesting they are at risk for suicide. Participants assigned to the treatment condition are presented an individualized cognitive-behavioral (CB) intervention. The CB intervention takes 45-60 minutes, is delivered by phone, and has been shown to promote treatment-seeking including in a preliminary study of OEF/OIF Veterans with elevated posttraumatic stress disorder (PTSD) symptoms. Participants are assessed at baseline and at 1-month, 3-month, 6-month, and 12-month follow-up. Analyses are based on logistic and mixed effect models. Specific Aims are as follows:
1) Test the effectiveness of the intervention on attitudes toward behavioral health treatment among at-risk service members. Hypothesis 1a:
Participants receiving the CB intervention will have significant increases in positive attitudes about treatment at 1-month follow-up compared to controls. Hypothesis 1b: Participants receiving the CB intervention will have significant increases in the intention to initiate behavioral health treatment compared to controls.
2) Test the effectiveness of the intervention on the initiation of and adherence to behavioral health treatment. Hypothesis 2a:
The brief (45-60 min), practical (delivered by phone), and promising nature of the CB intervention (favorable preliminary data in OEF/OIF Veterans with elevated PTSD symptoms) indicate its potential for wider implementation to reduce suicide risk among service members.
OVERALL PROJECT SUMMARY
Recruitment for this trial began on March 2, 2013. We aimed to recruit approximately 250 individuals during each year of the trial, and have 788 participants as of February 2017. Of the 788 participants, 651 of them are separated from the service, 109 are active in the National Guard or Reserves, and 28 are Active Duty.
Baseline characteristics.
Characteristics of the participant sample that have been entered into the data management system are presented in Table 1 in the Appendix. The mean age of participants is approximately 31 years old, and 90% of the sample is male. The majority of participants identify their race as white, non-Hispanic. The vast majority reported service in the Army. Baseline symptom severity scores indicate that both the intervention and control groups reported moderately severe symptoms of depression (mean score = 18) as measured by the PHQ9 and PTSD (mean score = 62) as measured by the PCL.
Forty-two percent of the sample reported a previous suicide attempt during the baseline assessment. The majority of the attempts involved the use of medications and or alcohol. Overdosing on medications is also the most frequently reported method when asked if they have a plan for suicide. Other reported methods involve guns, cutting, car accidents, and carbon monoxide poisoning.
We have had four participants die during the trial. One participant died from heart failure related to the use of fentanyl, three died as a result of drug overdose. One of these overdoses was categorized as a suicide. All of these outcomes were reported to all IRB's involved and were judged to be unrelated to study participation.
No SAE's have occurred during this trial period.
Study Activities
In June 2016, this award was transferred from Dartmouth Medical School to the Medical University of South Carolina with the PI. At that point all recruitment and study activities ceased. As of February 2017, the award had not yet arrived to MUSC. Study activities will recommence when the award arrives at MUSC. 
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